University of Louisville / James Graham Brown Cancer Center Louisville 529-539 is a clinical research site located in Louisville, Kentucky, United States 40202.
Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.
University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has participated in 1 clinical trials.
Therapeutic areas: Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).
Sponsors: Novartis Pharmaceuticals.
Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has 1 clinical trials on record. Their work covers Acute Myeloid Leukemia (AML) With, FLT3 Mutation, Internal Tandem Duplication (ITD) or Tyrosine Kinase Domain (TKD).
University of Louisville / James Graham Brown Cancer Center Louisville 529-539 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.